An experimental human papillomavirus vaccine made by Merck could offer a boost to the vaccine market, but the company will have to use effective marketing efforts to ensure uptake, according to a new study.
An advisory committee of the Centers for Disease Control and Prevention is recommending that all boys ages 11 and 12 years old get vaccinated against human papillomavirus, the CDC said Tuesday.
The Food and Drug Administration has declined to approve a vaccine developed by GlaxoSmithKline, the drug maker said.
GlaxoSmithKline is making a donation that it said would give more than 10,000 girls and women access to human papillomavirus vaccination.
British drug maker GlaxoSmithKline has stopped a late-stage trial of a vaccine for genital herpes,...